These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37347415)

  • 1. Impact of intensified prevention measures on rates of hospital-acquired bloodstream infection in medical-surgical intensive care units, Israel, 2011 to 2019.
    Ben-David D; Vaturi A; Wulffhart L; Temkin E; Solter E; Carmeli Y; Schwaber MJ; ;
    Euro Surveill; 2023 Jun; 28(25):. PubMed ID: 37347415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-series analysis to observe the impact of a centrally organized educational intervention on the prevention of central-line-associated bloodstream infections in 32 German intensive care units.
    Hansen S; Schwab F; Schneider S; Sohr D; Gastmeier P; Geffers C
    J Hosp Infect; 2014 Aug; 87(4):220-6. PubMed ID: 24973015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between implementation of second-tier prevention practices and CLABSI incidence: A national survey.
    Ben-David D; Vaturi A; Solter E; Temkin E; Carmeli Y; Schwaber MJ;
    Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1094-1099. PubMed ID: 31339089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal interventions for bundle implementation to decrease central line-associated bloodstream infections in adult intensive care units in a teaching hospital in Taiwan, 2009-2013.
    Lin WP; Chang YC; Wu UI; Hung MC; Chuang PY; Wang JT; Sheng WH; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):644-651. PubMed ID: 28888825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line-associated bloodstream infection rates.
    Álvarez-Moreno CA; Valderrama-Beltrán SL; Rosenthal VD; Mojica-Carreño BE; Valderrama-Márquez IA; Matta-Cortés L; Gualtero-Trujillo SM; Rodríguez-Peña J; Linares-Miranda CJ; Gonzalez-Rubio ÁP; Vega-Galvis MC; Riaño-Forero I; Ariza-Ayala BE; García-Laverde G; Susmann O; Mancera-Páez O; Olarte N; Rendón-Campo LF; Astudillo Y; Trullo-Escobar MD; Orellano PW
    Am J Infect Control; 2016 Nov; 44(11):e235-e241. PubMed ID: 27317408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a national bundle care program to reduce central line-associated bloodstream infections in intensive care units in Taiwan.
    Lai CC; Cia CT; Chiang HT; Kung YC; Shi ZY; Chuang YC; Lee CM; Ko WC; Hsueh PR;
    J Microbiol Immunol Infect; 2018 Oct; 51(5):666-671. PubMed ID: 29108783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central-Line-Associated Bloodstream Infections in Québec Intensive Care Units: Results from the Provincial Healthcare-Associated Infections Surveillance Program (SPIN).
    Li L; Fortin E; Tremblay C; Ngenda-Muadi M; Quach C;
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1186-94. PubMed ID: 27430754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative.
    Marsteller JA; Hsu YJ; Weeks K
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S209-15. PubMed ID: 25239712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with prevention practices and their association with central line-associated bloodstream infections in neonatal intensive care units.
    Zachariah P; Furuya EY; Edwards J; Dick A; Liu H; Herzig CT; Pogorzelska-Maziarz M; Stone PW; Saiman L
    Am J Infect Control; 2014 Aug; 42(8):847-51. PubMed ID: 25087136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of tailored interventions in a statewide programme to reduce central line-associated bloodstream infections.
    Assis DB; Madalosso G; Padoveze MC; Lobo RD; Oliveira MS; Boszczowski Í; Singer JM; Levin AS
    J Hosp Infect; 2018 Nov; 100(3):e163-e168. PubMed ID: 29730142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance with international prevention guidelines for central-line-associated bloodstream infections in neonatal intensive care units in Belgium: a national survey.
    Mahieu L; Van Damme K; Mertens K; Pierart J; Tackoen M; Cossey V
    J Hosp Infect; 2022 Nov; 129():49-57. PubMed ID: 35944792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year surveillance of central line-associated bloodstream infections in South Korea: Surveillance not enough, action needed.
    Kim EJ; Kang SY; Kwak YG; Kim SR; Shin MJ; Yoo HM; Han SH; Kim DW; Choi YH;
    Am J Infect Control; 2020 Mar; 48(3):285-289. PubMed ID: 31493935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey.
    Son CH; Daniels TL; Eagan JA; Edmond MB; Fishman NO; Fraser TG; Kamboj M; Maragakis LL; Mehta SA; Perl TM; Phillips MS; Price CS; Talbot TR; Wilson SJ; Sepkowitz KA
    Infect Control Hosp Epidemiol; 2012 Sep; 33(9):869-74. PubMed ID: 22869259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
    Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
    Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliminating central line-associated bloodstream infections: a national patient safety imperative.
    Berenholtz SM; Lubomski LH; Weeks K; Goeschel CA; Marsteller JA; Pham JC; Sawyer MD; Thompson DA; Winters BD; Cosgrove SE; Yang T; Louis TA; Meyer Lucas B; George CT; Watson SR; Albert-Lesher MI; St Andre JR; Combes JR; Bohr D; Hines SC; Battles JB; Pronovost PJ;
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):56-62. PubMed ID: 24334799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multistate programme to reduce catheter-associated infections in intensive care units with elevated infection rates.
    Meddings J; Greene MT; Ratz D; Ameling J; Fowler KE; Rolle AJ; Hung L; Collier S; Saint S
    BMJ Qual Saf; 2020 May; 29(5):418-429. PubMed ID: 31911543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to minimize central line-associated bloodstream infections in a neonatal intensive care unit: a quality improvement intervention based on a retrospective analysis and the adoption of an evidence-based bundle.
    Bierlaire S; Danhaive O; Carkeek K; Piersigilli F
    Eur J Pediatr; 2021 Feb; 180(2):449-460. PubMed ID: 33083900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the intensive care unit bundle: Implementation of a successful hospital-wide initiative to reduce central line-associated bloodstream infections.
    Klintworth G; Stafford J; O'Connor M; Leong T; Hamley L; Watson K; Kennon J; Bass P; Cheng AC; Worth LJ
    Am J Infect Control; 2014 Jun; 42(6):685-7. PubMed ID: 24837122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central Line-Associated Bloodstream Infection Reduction and Bundle Compliance in Intensive Care Units: A National Study.
    Furuya EY; Dick AW; Herzig CT; Pogorzelska-Maziarz M; Larson EL; Stone PW
    Infect Control Hosp Epidemiol; 2016 Jul; 37(7):805-10. PubMed ID: 27052993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
    Worth LJ; Brett J; Bull AL; McBryde ES; Russo PL; Richards MJ
    Am J Infect Control; 2009 Oct; 37(8):643-8. PubMed ID: 19589619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.